5361 - 5370 of 6466 Results
Title
Year
-
OPENTitle: Topological Abnormalities of Functional Brain Network in Early-Stage Parkinson’s Disease Patients With Mild Cognitive ImpairmentJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 616872End Page: 616872Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.616872Best OA location URL: https://doi.org/10.3389/fnins.2020.616872Citation Count: 35
-
OPENTitle: Expanding the phenotype of PPP1R21‐related neurodevelopmental disorderJournal Name: Clinical GeneticsPublisher: WileyVol: 105Issue #: 6Start Page: 620End Page: 629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/cge.14492Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11065596/pdf/nihms-1961168.pdfCitation Count: 6
-
OPENTitle: PseudoSorter: A self-supervised spike sorting approach applied to reveal Tau-induced reductions in neuronal activityJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 11Start Page: eadr4155End Page: eadr4155Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adr4155Best OA location URL: https://doi.org/10.1126/sciadv.adr4155Citation Count: 5
-
OPENTitle: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 16End Page: 16Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00162-1Best OA location URL: https://www.nature.com/articles/s41531-021-00162-1.pdfCitation Count: 27
-
OPENTitle: Cognition and future depression: associations with risk in those with and without a history of depressionJournal Name: BMJ Mental HealthPublisher: BMJVol: 29Issue #: 1Start Page: e302332End Page: e302332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjment-2025-302332Best OA location URL: https://doi.org/10.1136/bmjment-2025-302332Citation Count: 0
-
OPENTitle: The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier statusJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 43End Page: 43Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00778-8Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-021-00778-8Citation Count: 69
-
OPENTitle: Walking Speed Reliably Measures Clinically Significant Changes in Gait by Directional Deep Brain StimulationJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 618366End Page: 618366Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.618366Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.618366/pdfCitation Count: 11
-
OPENTitle: Genetic control of the human brain proteomeJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 108Issue #: 3Start Page: 400End Page: 410Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2021.01.012Best OA location URL: http://www.cell.com/article/S0002929721000124/pdfCitation Count: 117
-
OPENTitle: Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALSJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 642324End Page: 642324Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.642324Best OA location URL: https://doi.org/10.3389/fnins.2021.642324Citation Count: 8
-
OPENTitle: Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 645706End Page: 645706Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.645706Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.645706/pdfCitation Count: 24